{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:41:54Z","timestamp":1707525714838},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,14]]},"DOI":"10.7759\/cureus.52255","type":"journal-article","created":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T14:44:15Z","timestamp":1705243455000},"source":"Crossref","is-referenced-by-count":0,"title":["Pneumococcal Septic Shock Syndrome: A Deadly Condition Despite Vaccination"],"prefix":"10.7759","author":[{"given":"Liliana","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Silva-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Artur","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-022-00097-y","article-title":"The remarkable history of pneumococcal vaccination: an ongoing challenge","volume":"14","author":"Musher DM","year":"2022","unstructured":"Musher DM, Anderson R, Feldman C. The remarkable history of pneumococcal vaccination: an ongoing challenge. Pneumonia (Nathan). 2022, 14:5. 10.1186\/s41479-022-00097-y","journal-title":"Pneumonia (Nathan)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm4065","article-title":"Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses","volume":"14","author":"Davies LR","year":"2022","unstructured":"Davies LR, Cizmeci D, Guo W, et al.. Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses. Sci Transl Med. 2022, 14:4065. 10.1126\/scitranslmed.abm4065","journal-title":"Sci Transl Med"},{"key":"ref3","unstructured":"GRESP Recommendations For Pneumococcal Vaccination in the Adult Population (> 18 years old) - 2022 Revision (Article in Portuguese). (2022). https.\/\/gresp.pt\/ficheiros\/recursos\/folhetos\/recomendacoes-gresp-vacinacao-anti-pneumococica.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12050732","article-title":"Systematic review and meta-analysis of the efficacy and effectiveness of pneumococcal vaccines in adults","volume":"12","author":"Farrar JL","year":"2023","unstructured":"Farrar JL, Childs L, Ouattara M, Akhter F, Britton A, Pilishvili T, Kobayashi M. Systematic review and meta-analysis of the efficacy and effectiveness of pneumococcal vaccines in adults. Pathogens. 2023, 12:732. 10.3390\/pathogens12050732","journal-title":"Pathogens"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2015.057","article-title":"Bacterial infections following splenectomy for malignant and nonmalignant hematologic diseases","volume":"7","author":"Leone G","year":"2015","unstructured":"Leone G, Pizzigallo E. Bacterial infections following splenectomy for malignant and nonmalignant hematologic diseases. Mediterr J Hematol Infect Dis. 2015, 7:2015057. 10.4084\/MJHID.2015.057","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6898","article-title":"Post-splenectomy sepsis: a review of the literature","volume":"12","author":"Tahir F","year":"2020","unstructured":"Tahir F, Ahmed J, Malik F. Post-splenectomy sepsis: a review of the literature. Cureus. 2020, 12:6898. 10.7759\/cureus.6898","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91234-y","article-title":"Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis","volume":"11","author":"Chen H","year":"2021","unstructured":"Chen H, Matsumoto H, Horita N, Hara Y, Kobayashi N, Kaneko T. Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis. Sci Rep. 2021, 11:11865. 10.1038\/s41598-021-91234-y","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318287f1de","article-title":"Specific antibody in IV immunoglobulin for postsplenectomy sepsis","volume":"41","author":"Nakamura K","year":"2013","unstructured":"Nakamura K, Doi K, Okamoto K, et al.. Specific antibody in IV immunoglobulin for postsplenectomy sepsis. Crit Care Med. 2013, 41:163-70. 10.1097\/CCM.0b013e318287f1de","journal-title":"Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9051016","article-title":"Invasive pneumococcal disease in adults in Portugal: the importance of serotypes 8 and 3 (2015-2018)","volume":"9","author":"Silva-Costa C","year":"2021","unstructured":"Silva-Costa C, Gomes-Silva J, Teodoro I, Ramirez M, Melo-Cristino J. Invasive pneumococcal disease in adults in Portugal: the importance of serotypes 8 and 3 (2015-2018). Microorganisms. 2021, 9:1016. 10.3390\/microorganisms9051016","journal-title":"Microorganisms"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Kobayashi M","year":"2022","unstructured":"Kobayashi M, Farrar JL, Gierke R, et al.. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:109-17. 10.15585\/mmwr.mm7104a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7203a1","article-title":"Pneumococcal vaccine for adults aged \u226519 years: recommendations of the Advisory Committee on Immunization Practices, United States, 2023","volume":"72","author":"Kobayashi M","year":"2023","unstructured":"Kobayashi M, Pilishvili T, Farrar JL, et al.. Pneumococcal vaccine for adults aged \u226519 years: recommendations of the Advisory Committee on Immunization Practices, United States, 2023. MMWR Recomm Rep. 2023, 72:1-39. 10.15585\/mmwr.rr7203a1","journal-title":"MMWR Recomm Rep"},{"key":"ref12","unstructured":"Invasive Pneumococcal Disease. annual epidemiological report for 2018. (2020). https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER_for_2018_IPD.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/218062-pneumococcal-septic-shock-syndrome-a-deadly-condition-despite-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:09Z","timestamp":1707509649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/218062-pneumococcal-septic-shock-syndrome-a-deadly-condition-despite-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,14]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.52255","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,14]]}}}